Matei Deliu-Victor, Rocco Bernardo, Varela Rodolfo, Verweij Fabrizio, Scardino Epifanio, Renne Giuseppe, De Cobelli Ottavio
European Institute of Oncology, Milan, Italy.
Anticancer Res. 2005 Jan-Feb;25(1B):579-86.
The coexistence of multiple and synchronous primary neoplasms in the same organ (including kidney) has only rarely been described in the literature. We herein present a case of collecting duct carcinoma (CDC) combined with papillary renal carcinoma (RCC) having a 57-month disease-free survival CDC is a rather rare and aggressive neoplasm of the kidney. Sharing probably the same embryological origin, synchronous or metachronous association with in situ orpapillary transitional cell carcinoma (TCC) may be found; association with RCC has been only once reported in the literature. The high incidence of c-erbB-2 oncogene amplification in CDC further characterizes this tumor as a separate entity from renal cell carcinoma, and shows some genetic characteristics in common with TCC. The histological diagnosis of Bellini CDC can be confirmed by the positive immunohistochemical staining with a collecting duct marker and distal tubule marker and negative staining with a proximal tubule marker.
同一器官(包括肾脏)中多个同步原发性肿瘤的共存情况在文献中鲜有描述。我们在此报告一例集合管癌(CDC)合并乳头状肾细胞癌(RCC)的病例,该患者无病生存57个月。CDC是一种相当罕见且侵袭性强的肾脏肿瘤。可能具有相同的胚胎学起源,可发现其与原位或乳头状移行细胞癌(TCC)存在同步或异时关联;与RCC的关联在文献中仅报道过一次。CDC中c-erbB-2癌基因扩增的高发生率进一步表明该肿瘤是与肾细胞癌不同的独立实体,并且显示出与TCC有一些共同的遗传特征。通过使用集合管标志物和远端小管标志物进行免疫组化染色阳性以及近端小管标志物染色阴性可确诊贝利尼集合管癌的组织学诊断。